Henagliflozin

DB11939InvestigationalSmall molecule

Henagliflozin has been used in trials studying the treatment of Type 2 Diabetes.

Mechanism: Pharmacologically active on Sodium/glucose cotransporter 2
Curator reviewed
Formula / weight: C₂₂H₂₄ClFO₇ · 454.88 g/mol (avg)
Code names: SHR-3824

Resolves to

Compound

Structure

InChIKeyHYTPDMFFHVZBOR-VNXMGFANSA-NSMILESCCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]23OC[C@@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1F

Targets

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

26Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Henagliflozin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.